share_log

Apollomics Regains Compliance With Nasdaq's Minimum Bid Price Requirement

Benzinga ·  Dec 11 05:15

Apollomics Inc. (NASDAQ:APLM) (the "Company"), a clinical-stage biopharmaceutical company developing medicines to address difficult-to-treat cancers, today announced that on December 10, 2024, it received a notification (the "Notice") from The Nasdaq Stock Market LLC ("Nasdaq") stating that the Company has regained compliance with the requirement to maintain a minimum closing bid price of $1.00 per share, as set forth in Nasdaq Rule 5550(a)(2) (the "Bid Price Requirement"), and Nasdaq has determined to continue the listing of the Company's Class A ordinary shares ("Class A Ordinary Shares") on the Nasdaq Capital Market under the symbol "APLM."

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment